Literature Review
Volume 5 Issue 11 - 2021
Prevalence of Maternal Depression and Anxiety during COVID-19 Pandemic
Shafi U Bhuiyan1,2*, Housne Begum2,3, Tasmia Tazrin2, Fouzia Uzma2, Surbhi Singh2, Erum Zaidi2, Nurullhude Ziya2 and Romana Sheikh2
1University of Toronto, Canada
2Ryerson University, Canada
3McMaster University, Canada
*Corresponding Author: Shafi U Bhuiyan, University of Toronto and Ryerson University, Canada.
Received: September 21, 2021; Published: October 21, 2021




Abstract

Introduction: The declaration of the COVID-19 pandemic has impacted the mental well-being of individuals globally, among which the maternal population is among the most vulnerable. This study aims to explore the prevalence of maternal depression and anxiety during the COVID-19 pandemic. 

Materials and Methods: This article is a rapid review, consisting of a compilation of 18 related studies to investigate the prevalence of depression and anxiety in maternal women. The studies were selected based on our pre-set inclusion and exclusion criteria. The databases used are PubMed, Google Scholar, Medline (Ovid), and EMBASE with the following keywords: “maternal”, “depression”, “anxiety”, “COVID-19” and “pandemic”.

Results: The data from 18 studies were assembled to formulate this rapid review. Multiple scales such as the State-Trait Anxiety Inventory, Generalized Anxiety Disorder Scale, Edinburgh Postnatal Depression Scale, Zung Self-Rating Depression Scale, and more, were used in the 18 studies. The total number of participants was 47,237, and the studies included data from 9 different countries, where the prevalence of depression ranged from 11.40% to 58% and of anxiety ranging from 8.30% to 72%.

Conclusion: The impact of the COVID-19 pandemic had increased the prevalence of maternal depression and anxiety around the world. As COVID-19 is an ongoing issue, more studies are required to find the correlation between the pandemic and its effect on maternal mental health, as well as develop new strategies and effective interventions to alleviate the effects of COVID-19 on the maternal population.

Keywords: Maternal; Depression; Anxiety; COVID-19; Pandemic

References

  1. The WHO Just Declared Coronavirus COVID-19 a Pandemic (2021).
  2. Racine N., et al. “Maternal depressive and anxiety symptoms before and during the COVID-19 pandemic in Canada: a longitudinal analysis”. The Lancet Psychiatry5 (2021): 405-415.
  3. What Is Depression?” Psychiatry (2021).
  4. Lanes A., et al. “Prevalence and characteristics of Postpartum Depression symptomatology among Canadian women: a cross-sectional study”. BMC Public Health1 (2011).
  5. Tjornehoj T. “Hartgrove Behavioral Health System” (2021).
  6. Baby blues after pregnancy. Marchofdimes (2021).
  7. Davenport M., et al. “Moms Are Not OK: COVID-19 and Maternal Mental Health”. Frontiers in Global Women's Health (2020): 1.
  8. Lebel C., et al. “Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic”. Journal of Affective Disorders 277 (2020): 5-13.
  9. Cameron E., et al. “Maternal psychological distress and mental health service use during the COVID-19 pandemic”. Journal of Affective Disorders 276 (2020): 765-774.
  10. Perzow S., et al. “Mental health of pregnant and postpartum women in response to the COVID-19 pandemic”. Journal of Affective Disorders Reports 4 (2021): 100123.
  11. Chen H., et al. “Perinatal Anxiety and Depression During COVID-19”. The Journal for Nurse Practitioners1 (2021): 26-31.
  12. Ceulemans M., et al. “Mental health status of pregnant and breastfeeding women during the COVID‐19 pandemic—A multinational cross‐sectional study”. Acta Obstetricia et Gynecologica Scandinavica (2021).
  13. Fallon V., et al. “Psychosocial experiences of postnatal women during the COVID-19 pandemic. A UK-wide study of prevalence rates and risk factors for clinically relevant depression and anxiety”. Journal of Psychiatric Research 136 (2021): 157-166.
  14. Li C., et al. “The prevalence and risk factors of depression in prenatal and postnatal women in China with the outbreak of CoronaVirus Disease 2019”. Journal of Affective Disorders 282 (2021): 1203-1209.
  15. Yang X., et al. “Social, Cognitive, and eHealth Mechanisms of COVID-19 –Related Lockdown and Mandatory Quarantine That Potentially Affect the Mental Health of Pregnant Women in China: Cross-Sectional Survey Study”. Journal of Medical Internet Research1 (2021): e24495.
  16. Dong H., et al. “Investigation on the mental health status of pregnant women in China during the Pandemic of COVID-19”. Archives of Gynecology and Obstetrics2 (2020): 463-469.
  17. Zhou Y., et al. “The prevalence of psychiatric symptoms of pregnant and non-pregnant women during the COVID-19 epidemic”. Translational Psychiatry1 (2020).
  18. Wu Y., et al. “Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China”. American Journal of Obstetrics and Gynecology2 (2020): 240.e1-240.e9.
  19. Loret De Mola C., et al. “Maternal mental health before and during the COVID-19 pandemic in the 2019 Rio Grande birth cohort”. Brazilian Journal of Psychiatry (2021).
  20. Chaves C., et al. “Effects of the COVID-19 pandemic on perinatal mental health in Spain: Positive and negative outcomes”. Women and Birth (2021).
  21. Ayaz R., et al. “Anxiety and depression symptoms in the same pregnant women before and during the COVID-19 pandemic”. Journal of Perinatal Medicine9 (2020): 965-970.
  22. Durankuş F and Aksu E. “Effects of the COVID-19 pandemic on anxiety and depressive symptoms in pregnant women: a preliminary study”. The Journal of Maternal-Fetal and Neonatal Medicine (2020): 1-7.
  23. Effati-Daryani F., et al. “Depression, stress, anxiety and their predictors in Iranian pregnant women during the outbreak of COVID-19”. BMC Psychology1 (2020).
  24. Shahid A., et al. “Evaluation of psychological impact, depression, and anxiety among pregnant women during the COVID‐19 pandemic in Lahore, Pakistan”. International Journal of Gynecology and Obstetrics3 (2020): 462-465.
  25. Hessami K., et al. “COVID-19 pandemic and maternal mental health: a systematic review and meta-analysis”. The Journal of Maternal-Fetal and Neonatal Medicine (2020): 1-8.
  26. Nonacs R. “Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment—Correction”. JAMA: The Journal of the American Medical Association2 (2006): 170.
  27. Depression and anxiety: Exercise eases symptoms (2021).
  28. Sharma A., et al. “Exercise for Mental Health. The Primary Care Companion to”. The Journal of Clinical Psychiatry02 (2006): 106.
  29. Biaggi A., et al. “Identifying the women at risk of antenatal anxiety and depression: A systematic review”. Journal of Affective Disorders 191 (2016): 62-77.
  30. Baud D., et al. “Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection”. JAMA: The Journal of the American Medical Association21 (2020): 2198.
  31. Thapa S., et al. “Maternal mental health in the time of the COVID‐19 pandemic”. Acta Obstetricia et Gynecologica Scandinavica7 (2021): 817-818.
  32. Robinson L., et al. “Dual Diagnosis: Substance Abuse and Mental Health – HelpGuide (2021).
  33. Pfefferbaum B and North CS. “Mental health and the COVID-19 pandemic”. The New England Journal of Medicine 6 (2020): 510-512.
  34. Davenport MH., et al. “Impact of prenatal exercise on both prenatal and postnatal anxiety and depressive symptoms: a systematic review and meta-analysis”. British Journal of Sports Medicine 21 (2018): 1376-1385.
  35. Suzuki S. “Changes in psychological status of postpartum women due to the COVID-19 pandemic in Japan”. Journal of Maternal-Fetal and Neonatal Medicine 3 (2020): 1-2.
  36. Yim IS., et al. “Biological and psychosocial predictors of postpartum depression: systematic review and call for integration”. Annual Review of Clinical Psychology1 (2015): 99-137.
  37. Cooney GM., et al. “Exercise for depression”. Cochrane Database of Systematic Reviews9 (2013): CD004366.
  38. Fawcett E., et al. “The Prevalence of Anxiety Disorders During Pregnancy and the Postpartum Period” (2019).
Citation: Shafi U Bhuiyan., et al. “Prevalence of Maternal Depression and Anxiety during COVID-19 Pandemic”. EC Emergency Medicine and Critical Care 5.11 (2021): 22-32.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 25, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.